A Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel
Pharma Insight Briefings:
- Tuesday, Oct. 7 (11:30 - 12:45), room 520A/B.
"Essential update on contract manufacturing and quality standards".
Guy Villax, CEO of Hovione.
- Tuesday, Oct. 7 (16:00 - 17:00), room 520A/B.
"Apply Strategic Sourcing Methods towards Efficient API Development and Management".
Guy Villax, Vice-Chair of Rx-360.
- Wednesday, Oct. 8 (14:45 - 16:00), room 520A/B.
“Best Practices in Pharmaceutical Development and Manufacturing”.
Filipe Gaspar, Senior Director, Particle Engineering.